Cardiac sarcoidosis responding to monotherapy with infliximab

Clinical Rheumatology

Volumn 26, Issue 11, 2007, Pages 2001-2003

  Uthman, Imad ^a   Touma, Zahi ^a   Khoury, Maurice ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Heart block; Infliximab; Sarcoidosis; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; INFLIXIMAB;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; DRUG RESPONSE; ELECTROCARDIOGRAM; FEMALE; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG GRANULOMA; MONOTHERAPY; PRIORITY JOURNAL; SARCOIDOSIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HEART BLOCK; HEART DISEASES; HUMANS; LYMPH NODES; MYOCARDIUM; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 34948841526     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0614-1     Document Type: Article

References (15)

1. Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL et al (2004) Cardiac sarcoidosis: A retrospective study of 41 cases. Medicine (Baltimore) 83:315-334
2. Veinot JP, Johnston B (1998) Cardiac sarcoidosis - an occult cause of sudden death: A case report and literature review. J Forensic Sci 43:715-717
3. Sharma OP (2003) Diagnosis of cardiac sarcoidosis: An imperfect science, a hesitant art. Chest 123:18-19
4. Shabetai R (2000) Sarcoidosis and the heart. Curr Treat Options Cardiovasc Med 2:385-398
5. Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204-1211
6. Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26-31
7. Prior C, Knight RA, Herold M, Ott G, Spiteri MA (1996) Pulmonary sarcoidosis: Patterns of cytokine release in vitro. Eur Respir J 9:47-53
8. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620-4627
9. Baughman RP, Lower EE (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70-74
10. Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE (2003) Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542-3543
11. Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064-1071
12. Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: A dramatic response to infliximab. Am J Med 117:277-279
13. Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27-31
14. Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795-802
15. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133-3140